Dopamine D3 receptor knockout mice exhibit abnormal nociception in a sex-different manner

Peng Liu1, Bo Xing2, Zheng Chu1

  • 1College of Medicine & Forensics, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China.

Insights

Mice lacking the dopamine D3 receptor (D3RKO) show reduced pain responses. This study reveals sex-specific effects, with D3 receptor absence causing more pronounced hypoalgesia in female D3RKO mice across various pain tests.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Pain perception is complex and exhibits sex-based differences.
  • Dopamine D3 receptor knockout (D3RKO) mice demonstrate hypoalgesia, suggesting the D3 receptor's role in pain modulation.
  • Investigating sex-specific roles of the D3 receptor in nociception is crucial.

Purpose of the Study:

  • To investigate the sex-specific role of the dopamine D3 receptor in modulating nociception.
  • To compare pain responses in male and female D3RKO mice versus wild-type (WT) controls.

Main Methods:

  • Utilized hot-plate test for acute thermal pain at 52°C, 55°C, and 58°C.
  • Employed von Frey hair test for mechanical pain assessment.
  • Assessed persistent pain using the formalin test for peripheral tissue injury and inflammation.

Main Results:

  • D3RKO mice generally showed longer latencies in the hot-plate test compared to WT mice.
  • Male D3RKO mice exhibited hypoalgesia at 55°C, while female D3RKO mice showed a significant difference at 52°C.
  • Both male and female D3RKO mice displayed hypoalgesia in the von Frey test.
  • Female D3RKO mice showed significantly reduced late-phase nociception in the formalin test compared to WT females, unlike males.

Conclusions:

  • The dopamine D3 receptor plays a sex-specific role in modulating nociceptive behaviors.
  • Absence of the D3 receptor leads to increased analgesic behavior, particularly in female knockout mice.
  • These findings highlight the importance of considering sex as a biological variable in pain research and drug development targeting the D3 receptor.